ID   dH1f-RiPS-1.5
AC   CVCL_C702
DR   SKIP; SKIP000669
DR   SKIP; SKIP005175
DR   Wikidata; Q54831060
RX   PubMed=20888316;
CC   From: Harvard Medical School; Boston; USA.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U159 ! H1 Oct4-EGFP
SX   Male
AG   Blastocyst stage
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 17
//
RX   PubMed=20888316; DOI=10.1016/j.stem.2010.08.012; PMCID=PMC3656821;
RA   Warren L., Manos P.D., Ahfeldt T., Loh Y.-H., Li H., Lau F., Ebina W.,
RA   Mandal P.K., Smith Z.D., Meissner A., Daley G.Q., Brack A.S.,
RA   Collins J.J., Cowan C.A., Schlaeger T.M., Rossi D.J.;
RT   "Highly efficient reprogramming to pluripotency and directed
RT   differentiation of human cells with synthetic modified mRNA.";
RL   Cell Stem Cell 7:618-630(2010).
//